Voyager Therapeutics Inc
NASDAQ:VYGR

Watchlist Manager
Voyager Therapeutics Inc Logo
Voyager Therapeutics Inc
NASDAQ:VYGR
Watchlist
Price: 4.07 USD Market Closed
Market Cap: 226.3m USD

Intrinsic Value

The intrinsic value of one VYGR stock under the Base Case scenario is 3.84 USD. Compared to the current market price of 4.07 USD, Voyager Therapeutics Inc is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VYGR Intrinsic Value
3.84 USD
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Voyager Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about VYGR?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is VYGR valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Voyager Therapeutics Inc.

Explain Valuation
Compare VYGR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VYGR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Voyager Therapeutics Inc

Current Assets 220m
Cash & Short-Term Investments 208.9m
Receivables 4m
Other Current Assets 7m
Non-Current Assets 68m
Long-Term Investments 20m
PP&E 43m
Other Non-Current Assets 5m
Current Liabilities 35m
Accounts Payable 2.1m
Accrued Liabilities 23m
Other Current Liabilities 9.9m
Non-Current Liabilities 33m
Other Non-Current Liabilities 33m
Efficiency

Free Cash Flow Analysis
Voyager Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Voyager Therapeutics Inc

Revenue
31.3m USD
Operating Expenses
-172.3m USD
Operating Income
-141m USD
Other Expenses
15m USD
Net Income
-126m USD
Fundamental Scores

VYGR Profitability Score
Profitability Due Diligence

Voyager Therapeutics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
Declining Operating Margin
21/100
Profitability
Score

Voyager Therapeutics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

VYGR Solvency Score
Solvency Due Diligence

Voyager Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Voyager Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VYGR Price Targets Summary
Voyager Therapeutics Inc

Wall Street analysts forecast VYGR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VYGR is 15.3 USD with a low forecast of 8.08 USD and a high forecast of 26.25 USD.

Lowest
Price Target
8.08 USD
99% Upside
Average
Price Target
15.3 USD
276% Upside
Highest
Price Target
26.25 USD
545% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Voyager Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VYGR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

VYGR Insider Trading
Buy and sell transactions by insiders

VYGR News

What is the Intrinsic Value of one VYGR stock?

The intrinsic value of one VYGR stock under the Base Case scenario is 3.84 USD.

Is VYGR stock undervalued or overvalued?

Compared to the current market price of 4.07 USD, Voyager Therapeutics Inc is Overvalued by 6%.

Back to Top